Celgene Corporation to Present at Investor Conferences in May
Robert W. Baird Growth Stock Conference 2014 Bank of America Merrill Lynch
2014 Healthcare Conference UBS Global Life Science Conference 2014 Sanford C.
Bernstein Thirtieth Annual Strategic Decisions Conference
SUMMIT, N.J. -- April 25, 2014
Celgene Corporation (NASDAQ:CELG) announced that Celgene management will
provide an overview of the Company at four upcoming investor conferences in
the month of May. The conferences will be webcast live and a link to the
webcasts will be available in the Investor Relations section of the Company’s
website at www.celgene.com.
*Wednesday, May 7, 2014 at Baird's 2014 Growth Stock Conference in Chicago
at 10:10 a.m. ET
*Tuesday, May 13, 2014 at the Bank of America Merrill Lynch Healthcare
Conference in Las Vegas at 2:20 p.m. ET
*Monday, May 19, 2014 at the UBS Global Life Science Conference in New York
at 1:30 p.m. ET
*Thursday, May 29, 2014 at the Sanford C. Bernstein Thirtieth Annual
Strategic Decisions Conference in New York at 2:00 p.m. ET
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit www.celgene.com.
This press release contains forward-looking statements, which are generally
statements that are not historical facts. Forward-looking statements can be
identified by the words "expects," "anticipates," "believes," "intends,"
"estimates," "plans," "will," “outlook” and similar expressions.
Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We
undertake no obligation to update any forward-looking statement in light of
new information or future events, except as otherwise required by law.
Forward-looking statements involve inherent risks and uncertainties, most of
which are difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of factors,
many of which are discussed in more detail in our Annual Report on Form 10-K
and our other reports filed with the Securities and Exchange Commission.
Jacqualyn A. Fouse, PhD
EVP, Chief Financial Officer
Patrick E. Flanigan III
VP, Investor Relations
Press spacebar to pause and continue. Press esc to stop.